Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ancia D3 is a nutraceutical dietary supplement developed and marketed by Zoic Healthcare. It is formulated as an oral tablet containing a combination of multivitamins, multiminerals, zinc, and grape seed extract. The product is intended to support overall health by providing essential micronutrients and antioxidant support through its grape seed extract component. As a consumer health product, it is not a pharmaceutical drug candidate and does not have a formal clinical trial history or specific therapeutic target beyond general nutritional supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ancia D3.